NewswireToday - /newswire/ -
St Neots, Cambridgeshire, United Kingdom, 2012/02/09 - Clinicians at the Heart of England NHS Foundation Trust are benefitting from using SonoSite’s M-Turbo® and MicroMaxx® hand-carried ultrasound systems for vascular diagnostics and treatment guidance - SonoSite.com.
Corinna Gomm, Clinical Vascular Scientist at the Trust, explained: “The Vascular Centre is at Birmingham Heartlands Hospital, which has numerous SonoSite instruments, mainly MicroMaxx systems. These are used in both outpatient clinics – where their main uses are for scanning aortas, surveillance of abdominal aortic aneurysms (AAA) and for assessing veins prior to treatment – and in theatre, for ultrasound-guided treatment such as radiofrequency ablation of varicose veins (EVLA). Outpatient clinics and treatments also take place at Good Hope Hospital, where we have recently purchased an M-Turbo, and at Solihull, and the SonoSite systems have proved very capable of supporting satellite outpatient work when needed.”
“I also use the M-Turbo on the wards to perform carotid and leg arterial duplexes, and have been very pleased with its performance. It is robust, easy to use and the image is really clear, allowing me to perform intricate scans. We look at grey scale, colour and Doppler images and, as the system can penetrate down to 20 cm, it is very sensitive even in larger patients. The advanced needle visualisation feature is also popular with our consultants when performing ultrasound guided interventions. Minimal training was required as the systems are quite intuitive, and SonoSite’s technical advisors are very accessible. That is the beauty of SonoSite.”
For more information about SonoSite products, please contact:
Alexander House, 40A Wilbury Way, Hitchin SG4 0AP
T +44(0)14 6244 4800 / F +44(0)14 6244 4801 - E: ukresponse[.]sonosite.com
SonoSite, Inc. (sonosite.com) is the innovator and world leader in bedside and point-of-care ultrasound and an industry leader in ultra high-frequency micro-ultrasound technology and impedance cardiography equipment. Headquartered near Seattle, the company is represented by fourteen subsidiaries and a global distribution network in over 100 countries. SonoSite’s small, lightweight systems are expanding the use of ultrasound across the clinical spectrum by cost-effectively bringing high-performance ultrasound to the point of patient care. SonoSite, Ltd., a wholly owned subsidiary of SonoSite, Inc. based in Hitchin, Hertfordshire, oversees a direct sales distribution network in the UK and provides sales and marketing support for SonoSite's European offices.